• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估疫苗诱导的抗体活性针对:4CMenB 脑膜炎球菌疫苗诱导的交叉保护反应。

Evaluating vaccine-elicited antibody activities against : cross-protective responses elicited by the 4CMenB meningococcal vaccine.

机构信息

Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA.

出版信息

Infect Immun. 2023 Dec 12;91(12):e0030923. doi: 10.1128/iai.00309-23. Epub 2023 Nov 22.

DOI:10.1128/iai.00309-23
PMID:37991382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10715150/
Abstract

The bacterial pathogen is an urgent global health problem due to increasing numbers of infections, coupled with rampant antibiotic resistance. Vaccines against gonorrhea are being prioritized to combat drug-resistant . Meningococcal serogroup B vaccines such as four-component meningococcal B vaccine (4CMenB) are predicted by epidemiology studies to cross-protect individuals from natural infection with and elicit antibodies that cross-react with . Evaluation of vaccine candidates for gonorrhea requires a suite of assays for predicting efficacy and in animal models of infection, including the role of antibodies elicited by immunization. Here, we present the development and optimization of assays to evaluate antibody functionality after immunization of mice: antibody binding to intact , serum bactericidal activity, and opsonophagocytic killing activity using primary human neutrophils [polymorphonuclear leukocytes (PMNs)]. These assays were developed with purified antibodies against and used to evaluate serum from mice that were vaccinated with 4CMenB or given alum as a negative control. Results from these assays will help prioritize gonorrhea vaccine candidates for advanced preclinical to early clinical studies and will contribute to identifying correlates and mechanisms of immune protection against .

摘要

细菌性病原体由于感染人数不断增加,再加上抗生素耐药性的猖獗,是一个紧迫的全球健康问题。正在优先开发淋病疫苗,以对抗耐药性病原体。流脑 B 型疫苗(如四价脑膜炎 B 型疫苗[4CMenB])的流行病学研究预测,它可以交叉保护个体免受自然感染和产生与交叉反应的抗体。评估淋病疫苗候选物需要一系列预测功效的检测方法,以及在感染动物模型中,包括免疫接种引起的抗体的作用。在这里,我们介绍了用于评估小鼠免疫后抗体功能的检测方法的开发和优化:抗体与完整结合、血清杀菌活性和使用原代人中性粒细胞[多形核白细胞(PMN)]的调理吞噬杀伤活性。这些检测方法是用针对的纯化抗体开发的,并用于评估用 4CMenB 接种或用铝作为阴性对照的小鼠的血清。这些检测方法的结果将有助于优先考虑淋病疫苗候选物进行高级临床前到早期临床研究,并有助于确定针对的免疫保护相关性和机制。

相似文献

1
Evaluating vaccine-elicited antibody activities against : cross-protective responses elicited by the 4CMenB meningococcal vaccine.评估疫苗诱导的抗体活性针对:4CMenB 脑膜炎球菌疫苗诱导的交叉保护反应。
Infect Immun. 2023 Dec 12;91(12):e0030923. doi: 10.1128/iai.00309-23. Epub 2023 Nov 22.
2
Evaluating vaccine-elicited antibody activities against cross-protective responses elicited by the 4CMenB meningococcal vaccine.评估疫苗诱导的抗体活性对4CMenB脑膜炎球菌疫苗引发的交叉保护反应的影响。
bioRxiv. 2023 Aug 4:2023.08.03.551882. doi: 10.1101/2023.08.03.551882.
3
Protection against induced by OMV-based meningococcal vaccines are associated with cross-species directed humoral and cellular immune responses.基于外膜囊泡(OMV)的脑膜炎球菌疫苗诱导的保护作用与跨物种定向的体液免疫和细胞免疫反应相关。
Front Immunol. 2025 Apr 11;16:1539795. doi: 10.3389/fimmu.2025.1539795. eCollection 2025.
4
The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.基于 B 群脑膜炎奈瑟菌外膜囊泡的疫苗 4CMenB 可诱导针对淋病奈瑟菌的种间保护。
PLoS Pathog. 2020 Dec 8;16(12):e1008602. doi: 10.1371/journal.ppat.1008602. eCollection 2020 Dec.
5
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria.在致病性奈瑟菌鼻腔和生殖器定植的临床前模型中,佐剂对疫苗诱导的体液免疫反应和保护作用的依赖性影响。
Vaccine. 2025 Feb 27;48:126709. doi: 10.1016/j.vaccine.2025.126709. Epub 2025 Jan 15.
6
scavenges host sialic acid for Siglec-mediated, complement-independent suppression of neutrophil activation.它从宿主中摄取唾液酸,通过 Siglec 介导的、补体非依赖的方式抑制中性粒细胞的激活。
mBio. 2024 May 8;15(5):e0011924. doi: 10.1128/mbio.00119-24. Epub 2024 Apr 9.
7
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial.在马里,9月龄和15月龄儿童五价脑膜炎球菌结合疫苗(针对A、C、W、Y和X血清群)与常规儿童疫苗同时接种时的安全性和免疫原性:一项单中心、双盲、随机、对照、3期、非劣效性试验。
Lancet. 2025 Mar 29;405(10484):1069-1080. doi: 10.1016/S0140-6736(25)00046-7. Epub 2025 Mar 11.
8
Application of a novel virus-like particle platform to the development of Neisseria vaccines.一种新型病毒样颗粒平台在奈瑟菌疫苗研发中的应用。
J Biotechnol. 2025 Oct;406:190-197. doi: 10.1016/j.jbiotec.2025.07.012. Epub 2025 Jul 16.
9
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.在印度成年人中,五价脑膜炎球菌结合疫苗与四价脑膜炎球菌结合疫苗的安全性和免疫原性:一项观察者盲法、随机、活性对照、2/3期研究。
Lancet Infect Dis. 2025 Apr;25(4):399-410. doi: 10.1016/S1473-3099(24)00576-0. Epub 2024 Nov 6.
10
Promising developments in gonococcal vaccines.淋球菌疫苗的研究进展令人鼓舞。
Curr Opin Infect Dis. 2024 Feb 1;37(1):63-69. doi: 10.1097/QCO.0000000000000992. Epub 2023 Dec 4.

引用本文的文献

1
Effectiveness of the four-component protein-based meningococcal vaccine against infections: Mounting evidence and public health implications for Canada.基于蛋白质的四价脑膜炎球菌疫苗对感染的有效性:加拿大的越来越多的证据及公共卫生影响
Can Commun Dis Rep. 2025 Aug 28;51(8):312-318. doi: 10.14745/ccdr.v51i08a04. eCollection 2025 Aug.
2
Protection against induced by OMV-based meningococcal vaccines are associated with cross-species directed humoral and cellular immune responses.基于外膜囊泡(OMV)的脑膜炎球菌疫苗诱导的保护作用与跨物种定向的体液免疫和细胞免疫反应相关。
Front Immunol. 2025 Apr 11;16:1539795. doi: 10.3389/fimmu.2025.1539795. eCollection 2025.
3
Terminal complement complexes with or without C9 potentiate antimicrobial activity against .具有或不具有C9的末端补体复合物增强对……的抗菌活性。
mBio. 2025 May 14;16(5):e0014125. doi: 10.1128/mbio.00141-25. Epub 2025 Mar 31.
4
High-dimensional spectral flow cytometry of activation and phagocytosis by peripheral human polymorphonuclear leukocytes.人外周血多形核白细胞激活与吞噬作用的高维光谱流式细胞术
J Leukoc Biol. 2025 Apr 23;117(4). doi: 10.1093/jleuko/qiaf025.
5
Terminal complement complexes with or without C9 potentiate antimicrobial activity against .有或没有C9的末端补体复合物增强针对……的抗菌活性。
bioRxiv. 2025 Jan 16:2025.01.16.633325. doi: 10.1101/2025.01.16.633325.
6
High-dimensional spectral flow cytometry of activation and phagocytosis by peripheral human polymorphonuclear leukocytes.人外周多形核白细胞激活和吞噬作用的高维光谱流式细胞术
bioRxiv. 2024 Dec 5:2024.12.01.626241. doi: 10.1101/2024.12.01.626241.
7
In Vitro Pre-Clinical Evaluation of a Gonococcal Trivalent Candidate Vaccine Identified by Transcriptomics.通过转录组学鉴定的淋球菌三价候选疫苗的体外临床前评估
Vaccines (Basel). 2023 Dec 13;11(12):1846. doi: 10.3390/vaccines11121846.

本文引用的文献

1
Immune responses to and implications for vaccine development.针对 的免疫反应及其对疫苗开发的意义。
Front Immunol. 2023 Aug 17;14:1248613. doi: 10.3389/fimmu.2023.1248613. eCollection 2023.
2
An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol.一项评价 B 群脑膜炎奈瑟球菌(4CMenB)疫苗对男同性恋和双性恋男性淋病奈瑟菌感染疗效的开放性随机对照试验:MenGO 研究方案。
BMC Public Health. 2023 Mar 30;23(1):607. doi: 10.1186/s12889-023-15516-y.
3
Phagocytosis via complement receptor 3 enables microbes to evade killing by neutrophils.补体受体 3 介导的吞噬作用使微生物能够逃避中性粒细胞的杀伤。
J Leukoc Biol. 2023 Jul 1;114(1):1-20. doi: 10.1093/jleuko/qiad028.
4
Neisseria gonorrhoeae co-opts C4b-binding protein to enhance complement-independent survival from neutrophils.淋病奈瑟菌利用 C4b 结合蛋白增强补体非依赖性逃避中性粒细胞的吞噬作用。
PLoS Pathog. 2023 Mar 2;19(3):e1011055. doi: 10.1371/journal.ppat.1011055. eCollection 2023 Mar.
5
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study.B群脑膜炎球菌疫苗对HIV感染者淋病奈瑟菌感染的预防效果:一项病例对照研究
Sex Transm Dis. 2023 May 1;50(5):247-251. doi: 10.1097/OLQ.0000000000001771. Epub 2023 Jan 13.
6
Prevention of Neisseria gonorrhoeae With Meningococcal B Vaccine: A Matched Cohort Study in Southern California.用脑膜炎球菌 B 疫苗预防淋病奈瑟菌:南加州的一项匹配队列研究。
Clin Infect Dis. 2023 Feb 8;76(3):e1341-e1349. doi: 10.1093/cid/ciac436.
7
Recent Progress Towards a Gonococcal Vaccine.淋球菌疫苗的最新研究进展
Front Cell Infect Microbiol. 2022 Apr 11;12:881392. doi: 10.3389/fcimb.2022.881392. eCollection 2022.
8
Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational cohort and case-control study.四价脑膜炎球菌结合疫苗对婴儿、儿童和青少年计划中侵袭性 B 群脑膜炎奈瑟菌疾病和淋病的有效性和影响:一项观察性队列和病例对照研究。
Lancet Infect Dis. 2022 Jul;22(7):1011-1020. doi: 10.1016/S1473-3099(21)00754-4. Epub 2022 Apr 12.
9
Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis.淋病疫苗接种的公共卫生影响和成本效益:综合传播动力学健康经济建模分析。
Lancet Infect Dis. 2022 Jul;22(7):1030-1041. doi: 10.1016/S1473-3099(21)00744-1. Epub 2022 Apr 12.
10
Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study.B 群脑膜炎球菌外膜囊泡疫苗预防淋病的效果:一项回顾性观察研究。
Lancet Infect Dis. 2022 Jul;22(7):1021-1029. doi: 10.1016/S1473-3099(21)00812-4. Epub 2022 Apr 12.